Clinical Trials Logo

Clinical Trial Summary

New extended depth of focus intraocular lenses (IOLs) are being used in a broader spectrum of patients than trifocal IOLs. The purpose of this study is to evaluate visual improvement after cataract surgery in patients with glaucoma or ocular hypertension undergoing simultaneous cataract surgery with i-Stent implantation with the implantation of a Vivity IOL. Results will be compared with a group of glaucoma or ocular hypertension undergoing isolated cataract surgery with Vivity implantation, as well as with patients with no pathology undergoing cataract surgery and Vivity implantation


Clinical Trial Description

The purpose of this study is to report in detail visual function and patient satisfaction, as well as the need for spectacle correction, in patients with glaucoma and ocular hypertension undergoing cataract surgery with bilateral implantation of an extended depth of focus IOL, the Vivity IOL. The study also seeks to determine if there are differences in the speed of visual improvement between patients undergoing isolated cataract surgery and patients undergoing simultaneous i-Stent implantation. Results will also be compared with a group of patients with no ocular pathology undergoing cataract surgery with Vivity implantation. Patients will be asked to join the study once the type of surgery (isolated phacoemulsification versus phacoemulsification combined with i-Stent implantation) and the type of lens to be implanted (monofocal, EDoF, trifocal) has been agreed between ophthalmologist and patient. Therefore, inclusion in the study will have no influence on surgical indication. Once informed consent has been signed, the patient will be included in the study. Explorations specific for the study will be performed 3 and 12 months after surgery and include: Defocus curves Contrast sensitivity Self-reported photic phenomena Need for spectacle correction Satisfaction measured with the Catquest SF9 questionnaire Besides study-specific procedures, the following explorations which are standard of care will be performed one day, one week and one month after surgery: Uncorrected binocular visual acuity for distance, intermediate and near distances Monocular distance corrected and uncorrected visual acuity Residual subjective refraction Slit-lamp examination Intraocular pressure and number of hypotensive drugs required Description of any intra- or postsurgical complications ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05392738
Study type Observational
Source Clínica Rementería
Contact
Status Enrolling by invitation
Phase
Start date June 20, 2022
Completion date June 2024

See also
  Status Clinical Trial Phase
Recruiting NCT00563277 - Surgical Treatment of Concurrent Cataract and Primary Pterygium N/A
Completed NCT03512626 - Clinical Evaluation of Multifocal Intraocular Lens: OPTIVIS.TM N/A
Completed NCT05392998 - Tolerance to Residual Astigmatism in Eyes With Vivity®
Recruiting NCT04916041 - Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses
Withdrawn NCT03505827 - Visual Field Changes in TECNIS ZCB00 Monofocal vs. TECNIS Symfony Extended Depth of Focus Intraocular Lens Implantation
Completed NCT01202981 - Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality N/A
Recruiting NCT05827133 - Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation
Completed NCT04059289 - Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL
Completed NCT05430295 - Visual Acuity After Using A New Monofocal Intraocular Lens Compared To Standard Monofocal Lens N/A
Completed NCT05431868 - Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL
Completed NCT01873781 - A Pilot Study Simulating Multifocal Intraocular Lenses in Healthy Subjects N/A